| Serial Number | 99270242 |
| Word Mark | NOHO LABS |
| Filing Date | Monday, July 7, 2025 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, March 10, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 10, 2026 |
| Goods and Services | Telemedicine services; Health care services for treating aging and loss of biological function through peptide therapy; Providing personalized healthcare and medical information in the nature of peptide therapy; Health care services, namely, peptide therapy; Health care consulting in the field of peptide therapy; Providing healthy lifestyle and nutrition services, namely, personal assessments, personalized routines, maintenance schedules, and counseling |
| Goods and Services | Pharmaceutical preparations for peptide therapy for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders, age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes; Syringes sold filled with peptide preparations for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders, age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes; Pharmaceutical preparations for skin care; Therapeutic pharmaceutical for the treatment of aging, hormone imbalance, and other health conditions via peptide therapy; Pharmaceutical preparations for the treatment of aging-related conditions, hormone imbalances, and other health conditions via peptide therapy; Pharmaceutical preparations for the treatment and prevention of aging-related conditions; Diagnostic preparations for medical or veterinary purposes in the nature of peptide substrates; Synthetic peptides for the treatment and management of musculoskeletal and recovery conditions, namely muscle wasting, sarcopenia, soft tissue injuries, tendon injuries, and wound healing, dermatological conditions, namely skin aging, wrinkles, skin laxity, and hair loss, fatigue, energy, and cognitive conditions, namely chronic fatigue, low energy, age-related cognitive decline, and sleep disorders, age-related conditions, namely growth hormone deficiency, age-related muscle loss, and osteoporosis, inflammatory conditions, namely chronic inflammation and joint inflammation, sexual health disorders, namely erectile dysfunction, hypoactive sexual desire disorder, and hypogonadism, and metabolic disorders, namely obesity, overweight conditions, insulin resistance, and metabolic syndromes |
| NOT AVAILABLE | LABS |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 7, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 7, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Eterna Technologies Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94111 US |
| Party Name | Eterna Technologies Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94111 US |
| Event Date | Event Description |
| Monday, July 7, 2025 | NEW APPLICATION ENTERED |
| Monday, July 7, 2025 | APPLICATION FILING RECEIPT MAILED |
| Sunday, November 16, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, November 24, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, November 25, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 25, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, November 25, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 12, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 12, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 12, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 7, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 7, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 7, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, January 22, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, January 22, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 22, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 10, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 4, 2026 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 10, 2026 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 10, 2026 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |